Jerry S Rainforth

This from the Epoch Times:

Statins and COVID-19

Statin drugs lower cholesterol, especially what is called "bad” low-density lipoproteins (LDL) that carry cholesterol to our cells. Statins have been among the most common prescriptions in the United States for decades. In 2013, the American College of Cardiology and the American Heart Association recommended that everyone between the ages of 65 and 75 who were at elevated risk of cardiovascular disease (nearly everyone) be prescribed a statin drug. Then, by 2019, statins were a $10 billion market, and over 92 million people—35 percent of the U.S. population—mostly older adults, were taking statin drugs. This number was a threefold increase from the previous decade. By 2020, the United States ranked sixth in the world in per capita statin use.
So in 2019, the American public was about as saturated with statins as we had ever been.

Setting the Stage for COVID Vulnerability
The average age at death due to COVID-19 was 81, which was two to three years beyond the U.S. life expectancy at that time, so COVID-19 very disproportionately affected seniors, especially those with obesity, Type 2 diabetes, smoking, and more than two comorbidities.
COVID morbidity and mortality in the United States far exceeded worldwide numbers. The United States has 4 percent of the world’s population, but 33 percent of the world’s deaths from COVID-19. The United States also had by far the greatest number of diagnosed COVID-19 cases of any country—over 103 million—followed by India at 44 million. The United States had 1.1 million deaths attributed to COVID-19.

Epoc Times

Posted by: Timothy Birdnow at 08:20 AM | Comments (3) | Add Comment
Post contains 266 words, total size 2 kb.